Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-24-000057
Filing Date
2024-01-05
Accepted
2024-01-05 20:57:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 19402
2 GRAPHIC g530411dsp27a.jpg GRAPHIC 3592
3 GRAPHIC g530411dspp27.jpg GRAPHIC 8812
  Complete submission text file 0000950123-24-000057.txt   37750
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)